2025 annual financial data
Aquestive Therapeutics 2025 Operating margin
Direct answer
Operating margin was -156.36%.
Operating income was -69.65M USD and net income was -83.78M USD.
Operating cash flow was -52.43M USD.
Get free Aquestive Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 44.55M USD
- Operating income
- -69.65M USD
- Net income
- -83.78M USD
- Operating cash flow
- -52.43M USD